510(k) K210751
K210751 is an FDA 510(k) premarket notification submitted by Bc3 Technologies, Inc. for the device "S.E.A.L. Hemostatic Wound Spray". The FDA issued a decision of Substantially Equivalent on Feb 2, 2023. The device falls under product code QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics), a Class U device.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 2, 2023
- Date Received
- Mar 12, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hemostatic Wound Dressing Without Thrombin Or Other Biologics
- Device Class
- Class U
- Review Panel
- SU
- Submission Type
- 510(k)
To temporarily control bleeding and cover external wounds.
Need the full FDA record for Bc3 Technologies, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.